Metformin reduces hepatic glucose production, decreases intestinal glucose absorption, and increases peripheral insulin sensitivity, and may reduce appetite by raising glucagon like peptide-1 levels
How long does it take to start working
Efficacy Comparison Table Clinical trial data from the PIONEER program (Rybelsus) and SURPASS program (Mounjaro) provide a lot of evidence for comparing these medications: Mounjaro dominates across glycemic control and weight loss metrics, while Rybelsus leads with proven cardiovascular data from the SOUL trial
67 , 2031 (2005) Rasmussen, S
Although GIP receptor activation may exert anti-emetic effects through brainstem modulation, these effects appear insufficient to completely counterbalance GLP-1 mediated emesis during early treatment and dose escalation ( In contrast, glucagon receptor activation is independently associated with nausea and vomiting through both central and peripheral mechanisms, including effects on gastric motility and autonomic signaling
